What does Nigen do?
NIGEN specializes in the development of innovative genetic analysis tools and software. The company provides solutions for research and diagnostics in various fields, including healthcare and agriculture. NIGEN is committed to advancing genetic research through cutting-edge technology and user-friendly applications.
- Sectors
- Real estate agencies
- Activities
- Signals
-
ProfitableProfitable € 1.44M
The company reported a positive net result in the latest financial year.
Strong equityStrong equity € 38.72MStrong equity provides a buffer against setbacks.
Low riskLow risk 77.3%Good solvency (> 30%) points to long-term financial stability.
Good liquidityGood liquidity 12.28A healthy current ratio (≥ 1.5): enough current assets to cover short-term debt.
Positive cashflowPositive cashflow € 1.99MPositive operating cash flow in the latest financial year.
Positive EBITDAPositive EBITDA € 1.66MPositive EBITDA: operating activities are profitable.
Healthy social debtHealthy social debt 13.2%Social debts stay manageable relative to personnel costs.
- Investments
- Purcell Investments 100%, Main D'or 99,94%, Vlaams Asfaltbedrijf Huyghe En Cie 50%, +2 more
Financial ratios
|
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2025
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2024
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2023
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2022
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
|---|---|---|---|---|
|
€
1.94M
|
€
777K
|
€
202K
|
€
1.57M
|
|
|
€
1.66M
|
€
260K
|
€
-229K
|
€
1.37M
|
|
|
€
1.44M
|
€
222K
|
€
114K
|
€
438K
|
|
|
€
38.72M
|
€
37.28M
|
€
37.06M
|
€
37.09M
|
|
|
77.34%
|
75.49%
|
79.44%
|
79.93%
|
|
|
€
10.70M
|
€
11.57M
|
€
9.04M
|
€
8.75M
|
|
|
€
23.41M
|
€
24.19M
|
€
22.12M
|
€
21.10M
|
|
|
1.30
|
1.30
|
1.30
|
1.30
|
Publications 52
All publications- Maatschappelijke Zetel 23/01/2026
- Ontslagen - Benoemingen 16/05/2025
- Kapitaal - Aandelen - Rubriek Herstructurering (Fusie, Splitsing, Overdracht Vermogen, Enz...) 22/01/2025
- Ontslagen - Benoemingen 13/11/2024
- Rubriek Herstructurering (Fusie, Splitsing, Overdracht Vermogen, Enz...) 05/11/2024
Frequently asked questions
Answers to the most common questions about Nigen, based on official government data and the filed annual accounts.
What is the VAT number of Nigen?
The VAT number of Nigen is BE0425.690.735.
How many employees work at Nigen?
In 2025, Nigen employed 1.30 full-time equivalents (FTE).
When was Nigen established?
Nigen was founded in 15-03-1984.
What is the official address of Nigen?
The official address of Nigen is Mastendreef 21 Schilde 2970.
What is the legal form of Nigen?
The juridical form of Nigen is Public limited company (NV/SA).
What is the annual revenue of Nigen?
The 2025 accounts of Nigen do not report revenue. Smaller companies that file abbreviated accounts are not required to publish it.
What does Nigen do?
NIGEN specializes in the development of innovative genetic analysis tools and software. The company provides solutions for research and diagnostics in various fields, including healthcare and agriculture. NIGEN is committed to advancing genetic research through cutting-edge technology and user-friendly applications.
Is Nigen a reliable company?
Nigen is a registered Rechtspersoon with company number 0425.690.735 and can be verified through the official CBE database.
What is the credit limit of Nigen?
The estimated credit limit of Nigen is €3,504,477.
Is Nigen still active?
Nigen currently has the status "Normal situation" and is active.